IVF Hartmann Holding AG (SWX:VBSN)
Switzerland · Delayed Price · Currency is CHF 124.00
-2.50 (-1.98%)
Aug 4, 2026, 1:32 PM CET
IVF Hartmann Holding AG Revenue
In the year 2025, IVF Hartmann Holding AG had annual revenue of 167.35M CHF with 2.96% growth. IVF Hartmann Holding AG had revenue of 86.69M in the half year ending December 31, 2025, with 12.17% growth.
Revenue
167.35M
Revenue Growth
+2.96%
P/S Ratio
1.86
Revenue / Employee
580.12K
Employees
279
Market Cap
301.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 167.35M | 4.81M | 2.96% |
| Dec 31, 2024 | 162.54M | 10.48M | 6.89% |
| Dec 31, 2023 | 152.06M | -3.66M | -2.35% |
| Dec 31, 2022 | 155.71M | 4.71M | 3.12% |
| Dec 31, 2021 | 151.00M | -25.74M | -14.56% |
| Dec 31, 2020 | 176.74M | 32.91M | 22.88% |
| Dec 31, 2019 | 143.83M | 5.40M | 3.90% |
| Dec 31, 2018 | 138.44M | 1.24M | 0.91% |
| Dec 31, 2017 | 137.19M | 523.00K | 0.38% |
| Dec 31, 2016 | 136.67M | 2.22M | 1.65% |
| Dec 31, 2015 | 134.45M | -426.00K | -0.32% |
| Dec 31, 2014 | 134.87M | 5.85M | 4.53% |
| Dec 31, 2013 | 129.03M | -1.46M | -1.12% |
| Dec 31, 2012 | 130.49M | 8.91M | 7.32% |
| Dec 31, 2011 | 121.59M | -409.00K | -0.34% |
| Dec 31, 2010 | 122.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 45.81B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.16B |
| DocMorris AG | 1.12B |
| Ascom Holding AG | 291.90M |
| COLTENE Holding AG | 235.05M |
| Metall Zug AG | 194.62M |